Evidence map›Paper›PMID 37168471›Full record

ArticleJPGN reports2022

Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy.

Maitri Patel, Jeremy P Middleton, Howard P Goodkin, Barrett Barnes, Emily McGowan, Ryan Eid

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JPGN reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maitri PatelFrom the School of Medicine, University of Virginia, Charlottesville, VA.
Jeremy P MiddletonDepartment of Pediatrics, University of Virginia, Charlottesville, VA.
Howard P GoodkinDepartment of Neurology and Pediatrics, University of Virginia, Charlottesville, VA.
Barrett BarnesDivision of Pediatric Gastroenterology, University of Virginia School of Medicine, Charlottesville, VA.
Emily McGowanDivision of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, VA.
Ryan EidDivision of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD.
University of Virginia · USJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabidiol is used in the care of treatment-resistant epilepsy. It has been associated with varying side effects, ranging from somnolence to diarrhea and weight loss. We present a patient on chronic cannabidiol therapy who had persistent diarrhea, abdominal pain, weight loss, and esophageal eosinophilia that improved with cannabidiol dose adjustment.

Indexed as

cannabidiolcannabinoid receptor 1cannabinoid receptor 2chronic diarrheaeosinophilic esophagitisesophageal eosinophiliaplatelet activating factortetrahydrocannabinoltransient receptor potential cation channel subfamily V member 1

Identifiers

PMID37168471
PMCPMC10158314
OpenAlexW4298138596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.